Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details) - Schedule of summary of options granted to purchase

v3.22.2.2
Stockholders’ Equity (Details) - Schedule of summary of options granted to purchase
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Schedule Of Summary Of Options Granted To Purchase Abstract  
Number of Options, Outstanding at the beginning of period 4,084,549
Weighted average exercise price, Outstanding at the beginning of period (in Dollars per share) | $ / shares $ 3.95
Aggregate intrinsic value, Outstanding at the beginning of period (in Dollars) | $ $ 671
Number of Options, Granted 1,814,000
Weighted average exercise price, Granted (in Dollars per share) | $ / shares $ 1.14
Number of Options, Forfeited (868,141)
Weighted average exercise price, Forfeited (in Dollars per share) | $ / shares $ 4.08
Number of Options, Exercised
Weighted average exercise price, Exercised (in Dollars per share) | $ / shares
Number of Options, Outstanding at the end of period 5,030,408
Weighted average exercise price, Outstanding at the end of period (in Dollars per share) | $ / shares $ 2.92
Aggregate intrinsic value, Outstanding at the end of period (in Dollars) | $ $ 74
Exercisable at the end of period 2,691,163
Number of Options, Weighted average remaining contractual life – years 7 years 2 months 4 days